Pharmacologically targetable vulnerability in prostate cancer carrying RB1-SUCLA2 deletion

Susumu Kohno, Paing Linn, Naoko Nagatani, Yoshihiro Watanabe, Sharad Kumar, Tomoyoshi Soga, Chiaki Takahashi

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Fingerprint Dive into the research topics of 'Pharmacologically targetable vulnerability in prostate cancer carrying RB1-SUCLA2 deletion'. Together they form a unique fingerprint.

Medicine & Life Sciences